High volatility in Zomedica Pharmaceuticals Corp stock price on Wednesday which ended trading at $0.33

The Zomedica Pharmaceuticals Corp stock price fell by -10.59% on the last day (Wednesday, 23rd Feb 2022) from $0.37 to $0.33. During the day the stock fluctuated 16.67% from a day low at $0.33 to a day high of $0.39. The price has been going up and down for this period, and there has been a 13.01% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -4 million shares and in total, 20 million shares were bought and sold for approximately $6.70 million.

HC Wainwright is very positive about ZOM and gave it a "Buy" rating on Nov 16, 2020. The price target was changed from $0.50 to $0.30.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.Given the current short-term trend, the stock is expected to fall -15.65% during the next 3 months and, with a 90% probability hold a price between $0.22 and $0.33 at the end of this 3-month period.

The Zomedica Pharmaceuticals Corp stock holds a sell signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $0.35. On a fall, the stock will find some support from the long-term average at approximately $0.32. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, February 17, 2022, and so far it has fallen -17.52%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Zomedica Pharmaceuticals Corp finds support from accumulated volume at $0.33 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0550 between high and low, or 16.67%. For the last week, the stock has had a daily average volatility of 25.66%.

Zomedica Pharmaceuticals Corp holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.